• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Brazil·Financial Services·HAPV3.SA
Share

Hapvida Participacoes e Investimentos S.A. Stocks

R$ 10.55Last Updated 01.07.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

R$ 941.11M

R$ 10.55
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hapvida Participações e Investimentos S.A., operating alongside its affiliated companies, is a key player in the Brazilian healthcare sector. The organization provides a variety of health and dental insurance plans. Its service offerings extend to direct medical and paramedical care, complemented by a suite of diagnostic services such as laboratory analysis, imaging, and ultrasound. Additionally, Hapvida supports educational initiatives by organizing courses, lectures, seminars, and similar events. The company is also involved in the administration, consultancy, deployment, and sale of individual, family, and collective healthcare systems and plans. It manages the reimbursement of medical, dental, hospital, and general healthcare expenses for its members, while simultaneously offering direct medical and hospital services. Hapvida maintains an extensive operational infrastructure, comprising 85 hospitals, 77 emergency units, 318 clinics, and 269 diagnostic centers. The company was founded in 1979 and is headquartered in Fortaleza, Brazil.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
5/7

The average target price of HAPV3.SA is 13 and suggests 28.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.07.2026 19:23

Freedom Broker has removed Apple and 11 other stocks from its top picks. Who has taken their place?

02.07.2026 18:36

Tesla exceeded its delivery forecasts by nearly a quarter. Why are investors unhappy?

02.07.2026 17:38

U.S. job growth in June was half as strong as expected. What can we expect from the Fed?

02.07.2026 16:16

The U.S. could acquire a stake in OpenAI and other AI giants. This is Altman's proposal — FT

02.07.2026 16:06

In the EU, courts and regulators have pointed out banks’ overcompliance on three occasions. What should customers do?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026